NMPA Approval

Neostigmine Methylsulfate Injection

Approval Number

国药准字H20243285

Company杭州沐源生物医药科技有限公司

Registration Date

February 23, 2024

Drug Information

Generic Name

甲硫酸新斯的明注射液

Dosage Form

注射剂

Strength

1ml:0.5mg

Drug Type

化学药品

Registration Date

February 23, 2024

Company Information

Applicant Company

Company Name杭州沐源生物医药科技有限公司

Company Address

浙江省杭州市余杭区五常街道高顺路8-1号C座668室

Manufacturing Company

Company Name成都市海通药业有限公司

Company Address

成都市海峡两岸科技产业开发园柳台大道222号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.